Authors:
Broglio, F
Benso, A
Valetto, MR
Gottero, C
Quaranta, L
Podio, V
Arvat, E
Bobbio, M
Bisi, G
Ghigo, E
Citation: F. Broglio et al., Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy, ENDOCRINE, 14(1), 2001, pp. 105-108
Authors:
Tarella, C
Zallio, F
Caracciolo, D
Cuttica, A
Corradini, P
Gavarotti, P
Ladetto, M
Podio, V
Sargiotto, A
Rossi, G
Gianni, AM
Pileri, A
Citation: C. Tarella et al., High-dose mitoxantrone plus melphalan (MITO/L-PAM) as conditioning regimensupported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity, LEUKEMIA, 15(2), 2001, pp. 256-263
Authors:
Podio, V
Zara, GP
Carazzone, M
Cavalli, R
Gasco, MR
Citation: V. Podio et al., Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to rats, J PHARM PHA, 52(9), 2000, pp. 1057-1063
Authors:
Bisi, G
Podio, V
Valetto, FR
Broglio, F
Bertuccio, G
Del Rio, G
Boghen, MF
Berti, F
Muller, EE
Ghigo, E
Citation: G. Bisi et al., Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults, EUR J ENDOC, 140(4), 1999, pp. 322-327
Authors:
Bisi, G
Podio, V
Valetto, MR
Broglio, F
Bertuccio, G
Del Rio, G
Arvat, E
Boghen, MF
Deghenghi, R
Muccioli, G
Ong, H
Ghigo, E
Citation: G. Bisi et al., Acute cardiovascular and hormonal effects of GH and hexarelin, a syntheticGH-releasing peptide, in humans, J ENDOC INV, 22(4), 1999, pp. 266-272